Clinical Trial Update: A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This update covers a Phase 1 study of JADE201 in rheumatoid arthritis and notes that the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JADE201

Snippet

Sponsor: Jade Biosciences, Inc. | Conditions: Rhematoid Arthritis | Phase 1 | Status: NOT_YET_RECRUITING